Ryan Specialty (NYSE:RYAN) Price Target Raised to $55.00

Ryan Specialty logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Keefe, Bruyette & Woods raised its Ryan Specialty price target to $55 from $49 and maintained an “outperform” rating, implying 15.77% upside from the prior close.
  • Analyst sentiment is more mixed overall: the stock has a consensus “Hold” rating and an average price target of $52.97, with 8 Buy, 10 Hold, and 1 Sell ratings.
  • Ryan Specialty reported quarterly EPS of $0.51, beating the $0.49 estimate, while revenue of $789.96 million came in slightly below expectations.
  • Five stocks to consider instead of Ryan Specialty.

Ryan Specialty (NYSE:RYAN - Get Free Report) had its price target raised by equities researchers at Keefe, Bruyette & Woods from $49.00 to $55.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Keefe, Bruyette & Woods's price target indicates a potential upside of 15.77% from the stock's previous close.

A number of other research firms also recently weighed in on RYAN. Wells Fargo & Company raised their target price on shares of Ryan Specialty from $41.00 to $46.00 and gave the company an "equal weight" rating in a research report on Monday, November 2nd. Cantor Fitzgerald boosted their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the stock a "neutral" rating in a research report on Monday, August 3rd. The Goldman Sachs Group boosted their price target on shares of Ryan Specialty from $40.00 to $45.00 and gave the stock a "neutral" rating in a research report on Friday, July 31st. Weiss Ratings upgraded shares of Ryan Specialty from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, September 18th. Finally, Barclays raised their price objective on Ryan Specialty from $46.00 to $48.00 and gave the company an "overweight" rating in a report on Friday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $52.97.

Get Our Latest Stock Report on RYAN

Ryan Specialty Stock Up 1.9%

NYSE:RYAN traded up $0.89 during trading hours on Friday, reaching $47.51. 50,138 shares of the stock were exchanged, compared to its average volume of 2,185,638. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $58.91. The company has a debt-to-equity ratio of 4.03, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a 50 day moving average of $41.75 and a 200 day moving average of $38.99. The stock has a market cap of $11.95 billion, a PE ratio of 58.69, a PEG ratio of 1.02 and a beta of 0.54.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.02. The company had revenue of $789.96 million during the quarter, compared to analysts' expectations of $792.99 million. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. During the same period last year, the business earned $0.47 EPS. On average, equities analysts expect that Ryan Specialty will post 2.18 earnings per share for the current year.

Insider Activity at Ryan Specialty

In related news, CEO Benjamin Wuller sold 50,000 shares of the firm's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $47.31, for a total value of $2,365,500.00. Following the completion of the transaction, the chief executive officer directly owned 94,095 shares of the company's stock, valued at approximately $4,451,634.45. This trade represents a 34.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 52.03% of the company's stock.

Institutional Trading of Ryan Specialty

Several institutional investors and hedge funds have recently added to or reduced their stakes in RYAN. Allworth Financial LP lifted its stake in Ryan Specialty by 70.0% in the second quarter. Allworth Financial LP now owns 787 shares of the company's stock valued at $30,000 after acquiring an additional 324 shares during the last quarter. Fortitude Family Office LLC bought a new position in shares of Ryan Specialty in the 3rd quarter valued at about $34,000. Parallel Advisors LLC increased its stake in shares of Ryan Specialty by 54.9% during the 1st quarter. Parallel Advisors LLC now owns 1,013 shares of the company's stock worth $34,000 after purchasing an additional 359 shares during the last quarter. Jacobi Capital Management LLC acquired a new position in shares of Ryan Specialty during the 3rd quarter worth about $42,000. Finally, Integrated Wealth Concepts LLC acquired a new position in shares of Ryan Specialty during the 2nd quarter worth about $73,000. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

See Also

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines